PD-1 Monoclonal Antibody(Sixth Affiliated Hospital Sun Yat-Sen University)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NamePD-1 Monoclonal Antibody(Sixth Affiliated Hospital Sun Yat-Sen University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNasopharyngeal NeoplasmsColorectal NeoplasmsNasopharyngeal Carcinoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSixth Affiliated Hospital Sun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSixth Affiliated Hospital Sun Yat-Sen UniversitySun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsNasopharyngeal NeoplasmsColorectal NeoplasmsNasopharyngeal Carcinoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A